

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of B cell proliferation (GO:0030889) | 9.54705240 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 8.14028695 |
| 3 | complement activation (GO:0006956) | 8.11390417 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.89033392 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.67868924 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.67868924 |
| 7 | regulation of B cell proliferation (GO:0030888) | 6.28763721 |
| 8 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.84390425 |
| 9 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.84390425 |
| 10 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.84390425 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.81850542 |
| 12 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.75642268 |
| 13 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.73403361 |
| 14 | negative regulation of glucose import (GO:0046325) | 5.68342440 |
| 15 | B cell proliferation (GO:0042100) | 5.62419604 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 5.62324872 |
| 17 | regulation of regulatory T cell differentiation (GO:0045589) | 5.61529394 |
| 18 | regulation of B cell differentiation (GO:0045577) | 5.46910353 |
| 19 | regulation of MHC class II biosynthetic process (GO:0045346) | 5.40157867 |
| 20 | signal peptide processing (GO:0006465) | 5.13160731 |
| 21 | negative regulation of B cell activation (GO:0050869) | 5.10890550 |
| 22 | protein activation cascade (GO:0072376) | 5.09423963 |
| 23 | humoral immune response (GO:0006959) | 5.01894214 |
| 24 | regulation of chronic inflammatory response (GO:0002676) | 4.99924138 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.89580346 |
| 26 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.78817500 |
| 27 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.71088300 |
| 28 | negative regulation of glucose transport (GO:0010829) | 4.65339822 |
| 29 | regulation of B cell apoptotic process (GO:0002902) | 4.57561586 |
| 30 | regulation of B cell activation (GO:0050864) | 4.43703637 |
| 31 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.42638253 |
| 32 | cellular response to zinc ion (GO:0071294) | 4.32209276 |
| 33 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.27708213 |
| 34 | positive regulation of immunoglobulin production (GO:0002639) | 4.26666910 |
| 35 | cytidine deamination (GO:0009972) | 4.22211930 |
| 36 | cytidine metabolic process (GO:0046087) | 4.22211930 |
| 37 | cytidine catabolic process (GO:0006216) | 4.22211930 |
| 38 | mature B cell differentiation (GO:0002335) | 4.21186637 |
| 39 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 4.11023252 |
| 40 | regulation of immunoglobulin production (GO:0002637) | 4.10055151 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 3.98768871 |
| 42 | positive thymic T cell selection (GO:0045059) | 3.98520687 |
| 43 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.92040326 |
| 44 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.82083463 |
| 45 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.80806597 |
| 46 | negative thymic T cell selection (GO:0045060) | 3.79934871 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.74555879 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.73802016 |
| 49 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.69731680 |
| 50 | defense response to protozoan (GO:0042832) | 3.65392098 |
| 51 | retina homeostasis (GO:0001895) | 3.59567637 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.58339130 |
| 53 | negative regulation of cell killing (GO:0031342) | 3.58339130 |
| 54 | regulation of interferon-alpha production (GO:0032647) | 3.56719234 |
| 55 | regulation of isotype switching (GO:0045191) | 3.52026416 |
| 56 | response to interleukin-15 (GO:0070672) | 3.51750790 |
| 57 | negative T cell selection (GO:0043383) | 3.51578853 |
| 58 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.48252776 |
| 59 | tolerance induction (GO:0002507) | 3.47771549 |
| 60 | B cell activation (GO:0042113) | 3.47391115 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.44828213 |
| 62 | mature B cell differentiation involved in immune response (GO:0002313) | 3.42029075 |
| 63 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.41764759 |
| 64 | negative regulation of mononuclear cell proliferation (GO:0032945) | 3.40409034 |
| 65 | negative regulation of lymphocyte proliferation (GO:0050672) | 3.40409034 |
| 66 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.34302359 |
| 67 | thymic T cell selection (GO:0045061) | 3.33380832 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 3.31799483 |
| 69 | T cell selection (GO:0045058) | 3.30483032 |
| 70 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.28764466 |
| 71 | positive regulation of Rap GTPase activity (GO:0032854) | 3.28588780 |
| 72 | positive regulation of B cell proliferation (GO:0030890) | 3.26048624 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25878777 |
| 74 | lymphocyte costimulation (GO:0031294) | 3.25799167 |
| 75 | immune response-activating signal transduction (GO:0002757) | 3.25590295 |
| 76 | T cell lineage commitment (GO:0002360) | 3.25075101 |
| 77 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.24384478 |
| 78 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.23865143 |
| 79 | antimicrobial humoral response (GO:0019730) | 3.23162046 |
| 80 | antibacterial humoral response (GO:0019731) | 3.21215572 |
| 81 | negative regulation of leukocyte proliferation (GO:0070664) | 3.21148297 |
| 82 | positive regulation of B cell activation (GO:0050871) | 3.20172324 |
| 83 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.19595570 |
| 84 | response to protozoan (GO:0001562) | 3.18794587 |
| 85 | serine transport (GO:0032329) | 3.16890877 |
| 86 | negative regulation of T cell activation (GO:0050868) | 3.12804007 |
| 87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.12372163 |
| 88 | intestinal epithelial cell development (GO:0060576) | 3.11906715 |
| 89 | B cell differentiation (GO:0030183) | 3.11062763 |
| 90 | T cell costimulation (GO:0031295) | 3.09894839 |
| 91 | response to inactivity (GO:0014854) | 3.08417609 |
| 92 | respiratory burst (GO:0045730) | 3.06426211 |
| 93 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.01408730 |
| 94 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.01197907 |
| 95 | B cell homeostasis (GO:0001782) | 3.00208448 |
| 96 | leukocyte aggregation (GO:0070486) | 2.97874895 |
| 97 | L-serine transport (GO:0015825) | 2.97078045 |
| 98 | negative regulation of T cell proliferation (GO:0042130) | 2.92119935 |
| 99 | proline biosynthetic process (GO:0006561) | 2.91975243 |
| 100 | complement activation, classical pathway (GO:0006958) | 10.7185633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.26875842 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.04485514 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.51910127 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.47913356 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 4.44359762 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.89071467 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.77621357 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.66913782 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.19607115 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.08016614 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03034587 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.95618695 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.83636869 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.80712263 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.78477440 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.75573868 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73426640 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.72327110 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.70641591 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.66745305 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.63432901 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26854321 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.18327709 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.12872605 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05972645 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04208830 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01868968 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01289057 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00732246 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99792780 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95309153 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89187740 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83444943 |
| 34 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79308874 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77470359 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75012132 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71331003 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69361562 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68010808 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.63102551 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62066898 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54392662 |
| 43 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49909601 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.49314806 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46333039 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45607914 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42549149 |
| 48 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.40853217 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38950156 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38347863 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31995516 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31943806 |
| 53 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.27861908 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.27575690 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25184500 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16853000 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16553852 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13629420 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13357169 |
| 60 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02161307 |
| 61 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02061225 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00520757 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00416700 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99400288 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98965448 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98716010 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97865038 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96950916 |
| 69 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96088094 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96067050 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91722625 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90907302 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.90212188 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90083006 |
| 75 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.89659404 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88293668 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87690430 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86434552 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86186016 |
| 80 | GATA3_26560356_Chip-Seq_TH1_Human | 0.84331634 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84117111 |
| 82 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.83624648 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82923354 |
| 84 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78153983 |
| 85 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.78081449 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76988433 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.76536950 |
| 88 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76479260 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75662176 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75090396 |
| 91 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.74559241 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72183674 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70828841 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69436428 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.67102405 |
| 96 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.67096550 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.66969850 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.66729072 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65146427 |
| 100 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.63822368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 6.13272518 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.25195503 |
| 3 | MP0001800_abnormal_humoral_immune | 4.44911604 |
| 4 | MP0003300_gastrointestinal_ulcer | 4.28204092 |
| 5 | MP0001790_abnormal_immune_system | 4.28038709 |
| 6 | MP0005387_immune_system_phenotype | 4.28038709 |
| 7 | MP0001873_stomach_inflammation | 4.12940959 |
| 8 | MP0005671_abnormal_response_to | 4.01252458 |
| 9 | MP0002452_abnormal_antigen_presenting | 3.31420765 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.86750935 |
| 11 | MP0002723_abnormal_immune_serum | 2.84688429 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.69781143 |
| 13 | MP0001819_abnormal_immune_cell | 2.63768202 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.58211271 |
| 15 | MP0002398_abnormal_bone_marrow | 2.51434977 |
| 16 | MP0000716_abnormal_immune_system | 2.35219128 |
| 17 | MP0000685_abnormal_immune_system | 2.34715005 |
| 18 | MP0001853_heart_inflammation | 2.33115207 |
| 19 | MP0005310_abnormal_salivary_gland | 2.27059338 |
| 20 | MP0000689_abnormal_spleen_morphology | 2.16950448 |
| 21 | MP0005025_abnormal_response_to | 2.12895383 |
| 22 | MP0002933_joint_inflammation | 2.10368635 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.08281356 |
| 24 | MP0002429_abnormal_blood_cell | 1.88281672 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.86717578 |
| 26 | MP0002722_abnormal_immune_system | 1.86165073 |
| 27 | MP0001663_abnormal_digestive_system | 1.84119277 |
| 28 | MP0009785_altered_susceptibility_to | 1.83719794 |
| 29 | MP0003436_decreased_susceptibility_to | 1.81049769 |
| 30 | MP0006054_spinal_hemorrhage | 1.79170486 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.74770784 |
| 32 | MP0004947_skin_inflammation | 1.72592737 |
| 33 | MP0002419_abnormal_innate_immunity | 1.71369630 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.67073822 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.64912727 |
| 36 | MP0000490_abnormal_crypts_of | 1.61033721 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.59905337 |
| 38 | MP0002405_respiratory_system_inflammati | 1.56584324 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.55338504 |
| 40 | MP0006082_CNS_inflammation | 1.52883698 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.37336301 |
| 42 | MP0003866_abnormal_defecation | 1.35772164 |
| 43 | MP0001879_abnormal_lymphatic_vessel | 1.30386098 |
| 44 | MP0005381_digestive/alimentary_phenotyp | 1.26121050 |
| 45 | MP0004510_myositis | 1.21980096 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.13943143 |
| 47 | MP0002006_tumorigenesis | 1.13133467 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.11685609 |
| 49 | MP0001919_abnormal_reproductive_system | 1.07321461 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.06756372 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.06182685 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.04308293 |
| 53 | MP0001348_abnormal_lacrimal_gland | 0.99901188 |
| 54 | MP0005076_abnormal_cell_differentiation | 0.96218668 |
| 55 | MP0002693_abnormal_pancreas_physiology | 0.94440413 |
| 56 | MP0008469_abnormal_protein_level | 0.89048920 |
| 57 | MP0005464_abnormal_platelet_physiology | 0.86449032 |
| 58 | MP0002019_abnormal_tumor_incidence | 0.86233016 |
| 59 | MP0001533_abnormal_skeleton_physiology | 0.82517899 |
| 60 | MP0003183_abnormal_peptide_metabolism | 0.80137888 |
| 61 | MP0000477_abnormal_intestine_morphology | 0.79887578 |
| 62 | MP0001545_abnormal_hematopoietic_system | 0.77474975 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 0.77474975 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 0.74935283 |
| 65 | MP0003075_altered_response_to | 0.74671398 |
| 66 | MP0002136_abnormal_kidney_physiology | 0.73877149 |
| 67 | MP0003724_increased_susceptibility_to | 0.70118362 |
| 68 | MP0001542_abnormal_bone_strength | 0.67554297 |
| 69 | MP0003787_abnormal_imprinting | 0.61693470 |
| 70 | MP0005023_abnormal_wound_healing | 0.61337246 |
| 71 | MP0000003_abnormal_adipose_tissue | 0.60707665 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58662498 |
| 73 | MP0001905_abnormal_dopamine_level | 0.58375773 |
| 74 | MP0008874_decreased_physiological_sensi | 0.57798227 |
| 75 | MP0003045_fibrosis | 0.56415523 |
| 76 | MP0008872_abnormal_physiological_respon | 0.53803848 |
| 77 | MP0001944_abnormal_pancreas_morphology | 0.51891223 |
| 78 | MP0008057_abnormal_DNA_replication | 0.51641956 |
| 79 | MP0001191_abnormal_skin_condition | 0.50875673 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.50574265 |
| 81 | MP0001501_abnormal_sleep_pattern | 0.49339230 |
| 82 | MP0010094_abnormal_chromosome_stability | 0.48590645 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.48270278 |
| 84 | MP0000249_abnormal_blood_vessel | 0.46160615 |
| 85 | MP0008873_increased_physiological_sensi | 0.46088563 |
| 86 | MP0000609_abnormal_liver_physiology | 0.45400334 |
| 87 | MP0009278_abnormal_bone_marrow | 0.45315121 |
| 88 | MP0003795_abnormal_bone_structure | 0.42949507 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.42914552 |
| 90 | MP0002083_premature_death | 0.42575163 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.42395223 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.41022491 |
| 93 | MP0003879_abnormal_hair_cell | 0.39058665 |
| 94 | MP0003448_altered_tumor_morphology | 0.38818674 |
| 95 | MP0004957_abnormal_blastocyst_morpholog | 0.38675008 |
| 96 | MP0005166_decreased_susceptibility_to | 0.38538891 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.37861679 |
| 98 | MP0003077_abnormal_cell_cycle | 0.37259149 |
| 99 | MP0003123_paternal_imprinting | 0.35861743 |
| 100 | MP0005389_reproductive_system_phenotype | 0.35860784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.29710245 |
| 2 | Abnormality of B cell number (HP:0010975) | 6.78118983 |
| 3 | B lymphocytopenia (HP:0010976) | 6.78118983 |
| 4 | Recurrent bronchitis (HP:0002837) | 6.66728992 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.16950181 |
| 6 | Cellulitis (HP:0100658) | 6.15694924 |
| 7 | Meningitis (HP:0001287) | 5.90332143 |
| 8 | Gastrointestinal stroma tumor (HP:0100723) | 5.89830684 |
| 9 | Colitis (HP:0002583) | 5.84508770 |
| 10 | Papilloma (HP:0012740) | 5.60201884 |
| 11 | Verrucae (HP:0200043) | 5.60201884 |
| 12 | Recurrent viral infections (HP:0004429) | 5.07580900 |
| 13 | IgM deficiency (HP:0002850) | 4.90374601 |
| 14 | Inflammation of the large intestine (HP:0002037) | 4.80060644 |
| 15 | Optic neuritis (HP:0100653) | 4.68244272 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 4.68244272 |
| 17 | Vasculitis (HP:0002633) | 4.55966661 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 4.55869205 |
| 19 | Recurrent pneumonia (HP:0006532) | 4.44227402 |
| 20 | Pulmonary infiltrates (HP:0002113) | 4.39958525 |
| 21 | Myositis (HP:0100614) | 4.10579721 |
| 22 | Chronic sinusitis (HP:0011109) | 4.05793650 |
| 23 | Bronchitis (HP:0012387) | 3.96837798 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.91689836 |
| 25 | Recurrent lower respiratory tract infections (HP:0002783) | 3.89662912 |
| 26 | Orchitis (HP:0100796) | 3.89552932 |
| 27 | Osteomyelitis (HP:0002754) | 3.88036003 |
| 28 | Chronic otitis media (HP:0000389) | 3.86970686 |
| 29 | Abnormality of the prostate (HP:0008775) | 3.76066678 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.72497929 |
| 31 | Obstructive lung disease (HP:0006536) | 3.72497929 |
| 32 | Restrictive lung disease (HP:0002091) | 3.69619746 |
| 33 | Recurrent otitis media (HP:0000403) | 3.67194905 |
| 34 | Emphysema (HP:0002097) | 3.55583951 |
| 35 | IgA deficiency (HP:0002720) | 3.44560974 |
| 36 | Sepsis (HP:0100806) | 3.36565415 |
| 37 | Thyroiditis (HP:0100646) | 3.34228558 |
| 38 | Keratoconjunctivitis sicca (HP:0001097) | 3.33448108 |
| 39 | Lymphopenia (HP:0001888) | 3.29955726 |
| 40 | Skin rash (HP:0000988) | 3.25887239 |
| 41 | IgG deficiency (HP:0004315) | 3.23516841 |
| 42 | Hemoptysis (HP:0002105) | 3.15548253 |
| 43 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.15017666 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13652540 |
| 45 | Pulmonary embolism (HP:0002204) | 3.10980370 |
| 46 | Chest pain (HP:0100749) | 3.09124429 |
| 47 | Keratoconjunctivitis (HP:0001096) | 3.05695932 |
| 48 | Gangrene (HP:0100758) | 3.03483599 |
| 49 | Ureteral stenosis (HP:0000071) | 3.01137360 |
| 50 | Arterial thrombosis (HP:0004420) | 2.97892290 |
| 51 | Ureteral obstruction (HP:0006000) | 2.91145069 |
| 52 | Recurrent fungal infections (HP:0002841) | 2.87210688 |
| 53 | Eczematoid dermatitis (HP:0000976) | 2.85048823 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.81313679 |
| 55 | Small epiphyses (HP:0010585) | 2.79529827 |
| 56 | Encephalitis (HP:0002383) | 2.76369481 |
| 57 | Abnormality of T cells (HP:0002843) | 2.70124764 |
| 58 | T lymphocytopenia (HP:0005403) | 2.69343161 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.67480938 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.65927146 |
| 61 | Recurrent bacterial skin infections (HP:0005406) | 2.62848681 |
| 62 | Severe combined immunodeficiency (HP:0004430) | 2.48002600 |
| 63 | Mediastinal lymphadenopathy (HP:0100721) | 2.46600458 |
| 64 | Skin ulcer (HP:0200042) | 2.44971716 |
| 65 | Pulmonary fibrosis (HP:0002206) | 2.44037635 |
| 66 | Combined immunodeficiency (HP:0005387) | 2.38628846 |
| 67 | Mitral stenosis (HP:0001718) | 2.33377082 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.32496064 |
| 69 | Thrombophlebitis (HP:0004418) | 2.29564800 |
| 70 | Recurrent skin infections (HP:0001581) | 2.28196667 |
| 71 | Fatigue (HP:0012378) | 2.27028020 |
| 72 | Thrombocytosis (HP:0001894) | 2.25873670 |
| 73 | Polyneuropathy (HP:0001271) | 2.23968745 |
| 74 | Neutropenia (HP:0001875) | 2.23161265 |
| 75 | Lymphoma (HP:0002665) | 2.21100915 |
| 76 | Arthralgia (HP:0002829) | 2.17683149 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17120667 |
| 78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17120667 |
| 79 | Glomerulopathy (HP:0100820) | 2.10714816 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.04275040 |
| 81 | Nasal polyposis (HP:0100582) | 2.02800719 |
| 82 | Abnormality of the pericardium (HP:0001697) | 1.98789130 |
| 83 | Abnormality of the pleura (HP:0002103) | 1.97170070 |
| 84 | Bronchiectasis (HP:0002110) | 1.93833524 |
| 85 | Spontaneous hematomas (HP:0007420) | 1.86798979 |
| 86 | Vertebral arch anomaly (HP:0008438) | 1.86449918 |
| 87 | Leukopenia (HP:0001882) | 1.85689008 |
| 88 | Abnormality of male internal genitalia (HP:0000022) | 1.85010519 |
| 89 | Flattened epiphyses (HP:0003071) | 1.84422184 |
| 90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.83897255 |
| 91 | Dehydration (HP:0001944) | 1.80080177 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 1.79810480 |
| 93 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.78853440 |
| 94 | Petechiae (HP:0000967) | 1.75236008 |
| 95 | Abnormality of the fingertips (HP:0001211) | 1.74667560 |
| 96 | Viral hepatitis (HP:0006562) | 1.73754538 |
| 97 | Pustule (HP:0200039) | 1.72932786 |
| 98 | Chronic diarrhea (HP:0002028) | 1.71704606 |
| 99 | Epistaxis (HP:0000421) | 1.70052898 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.69302150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.50392244 |
| 2 | ERN1 | 5.57325016 |
| 3 | MAP4K1 | 5.19973232 |
| 4 | MAP3K10 | 3.06162601 |
| 5 | SYK | 2.74808872 |
| 6 | GRK6 | 2.71383679 |
| 7 | CSF1R | 2.23863346 |
| 8 | MAP3K14 | 2.17715261 |
| 9 | BTK | 2.08124980 |
| 10 | MAP3K13 | 1.98231856 |
| 11 | TAOK3 | 1.78023247 |
| 12 | RIPK4 | 1.73727534 |
| 13 | NME2 | 1.72027258 |
| 14 | TBK1 | 1.64729066 |
| 15 | STK10 | 1.64698669 |
| 16 | TYK2 | 1.62083757 |
| 17 | EIF2AK3 | 1.61627030 |
| 18 | LYN | 1.59142858 |
| 19 | JAK1 | 1.57850827 |
| 20 | JAK3 | 1.54533708 |
| 21 | FES | 1.54323933 |
| 22 | ITK | 1.53203428 |
| 23 | BLK | 1.44029403 |
| 24 | SIK2 | 1.41676635 |
| 25 | KIT | 1.41182208 |
| 26 | IRAK4 | 1.40104818 |
| 27 | LRRK2 | 1.38089420 |
| 28 | TEC | 1.27298727 |
| 29 | LMTK2 | 1.24713492 |
| 30 | HCK | 1.21459294 |
| 31 | NEK2 | 1.18933023 |
| 32 | LCK | 1.15861596 |
| 33 | PRKCH | 1.11190476 |
| 34 | PRKCQ | 1.09502028 |
| 35 | IKBKE | 1.01947823 |
| 36 | MST4 | 1.01161727 |
| 37 | NTRK3 | 0.97344596 |
| 38 | CSK | 0.96450436 |
| 39 | EEF2K | 0.94462788 |
| 40 | MATK | 0.91934335 |
| 41 | JAK2 | 0.89732263 |
| 42 | IKBKB | 0.87909241 |
| 43 | PIM1 | 0.86114766 |
| 44 | GRK1 | 0.85488180 |
| 45 | FGFR3 | 0.78316269 |
| 46 | HIPK2 | 0.76794744 |
| 47 | MARK3 | 0.75575747 |
| 48 | ZAP70 | 0.74972184 |
| 49 | SIK3 | 0.74584257 |
| 50 | FRK | 0.72145724 |
| 51 | FGFR4 | 0.69670453 |
| 52 | ALK | 0.69323522 |
| 53 | TGFBR2 | 0.68961103 |
| 54 | FYN | 0.65564096 |
| 55 | CCNB1 | 0.60527832 |
| 56 | CLK1 | 0.58314093 |
| 57 | PDK1 | 0.58198739 |
| 58 | CDC42BPA | 0.57801441 |
| 59 | MAPK11 | 0.57001536 |
| 60 | MAPK4 | 0.55927378 |
| 61 | CHUK | 0.54712904 |
| 62 | TRIB3 | 0.52963747 |
| 63 | CDK4 | 0.52381670 |
| 64 | PRPF4B | 0.51219367 |
| 65 | EPHB1 | 0.48658212 |
| 66 | ABL1 | 0.48390149 |
| 67 | FGR | 0.44729278 |
| 68 | PKN2 | 0.40212753 |
| 69 | MAP3K7 | 0.39891650 |
| 70 | INSR | 0.39705060 |
| 71 | MELK | 0.38819813 |
| 72 | PRKG2 | 0.38576965 |
| 73 | CDK12 | 0.38500606 |
| 74 | PRKCI | 0.36884488 |
| 75 | PRKCD | 0.36463495 |
| 76 | MAPK12 | 0.35539758 |
| 77 | MAPK7 | 0.34577781 |
| 78 | PRKD1 | 0.34303033 |
| 79 | SIK1 | 0.31660465 |
| 80 | RPS6KB2 | 0.29440389 |
| 81 | PIK3CG | 0.28878586 |
| 82 | NLK | 0.27782558 |
| 83 | CDK6 | 0.26868838 |
| 84 | PASK | 0.25867010 |
| 85 | PRKD2 | 0.24261097 |
| 86 | PDPK1 | 0.22048166 |
| 87 | CDK9 | 0.22006036 |
| 88 | MAPKAPK2 | 0.21736075 |
| 89 | EPHA3 | 0.21011187 |
| 90 | RPS6KA4 | 0.20495946 |
| 91 | EIF2AK1 | 0.19077128 |
| 92 | TNK2 | 0.18495998 |
| 93 | IRAK3 | 0.18253761 |
| 94 | NME1 | 0.17753526 |
| 95 | MAPK3 | 0.17111698 |
| 96 | FLT3 | 0.16759344 |
| 97 | MAP3K8 | 0.16135603 |
| 98 | CSNK1D | 0.15433372 |
| 99 | STK4 | 0.15283479 |
| 100 | EGFR | 0.14183045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 6.47647646 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.86585574 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.56499750 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.23809944 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.83470771 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.40239548 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.59798315 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.46395802 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.22480809 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.21138590 |
| 11 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.04688194 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03512813 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89589512 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79793283 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.58216774 |
| 16 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.51115011 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49178909 |
| 18 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.43741967 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30305625 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.22594739 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.21898905 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14975869 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.13682489 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11939773 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.11565415 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.09571978 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09393714 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98721211 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 0.97944939 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97366771 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95917598 |
| 32 | DNA replication_Homo sapiens_hsa03030 | 0.90765026 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88777222 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86750398 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84317029 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84214454 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 0.81757578 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 0.81270237 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76220257 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 0.74334997 |
| 41 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73254934 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71034826 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69567113 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65961622 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63647210 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 0.60209235 |
| 47 | Mismatch repair_Homo sapiens_hsa03430 | 0.58164955 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 0.54843531 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 0.54823881 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54272833 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52794090 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50124783 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50084797 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.48553838 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48434449 |
| 56 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47802871 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47552796 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47161866 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46844986 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46213888 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43042992 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42742509 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42236571 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40675537 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40643891 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37939276 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35892408 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35356787 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34538817 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30206197 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29632126 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29512325 |
| 73 | Spliceosome_Homo sapiens_hsa03040 | 0.28890344 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28064889 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.27724865 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26250229 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.25490427 |
| 78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24442979 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.24384083 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.24272283 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23507168 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.23046234 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22157317 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21836036 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.20548474 |
| 86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.19784146 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.18453289 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.18098810 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16412456 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15002737 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14315876 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.14200569 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.13948085 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.13698570 |
| 95 | Homologous recombination_Homo sapiens_hsa03440 | 0.13250151 |
| 96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.12589387 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.12542516 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12316879 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11794973 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10988667 |

